comprehensive -WSS

comprehensive

author：hotspot 2025-09-07 08:42:13 - browse：47

Sutter Health Palo Alto Medical Foundation facilities. health tech coverage from STAT — Adobe

When Sutter Health was on trial for anticompetitive conduct in 2022, the San Francisco jury missed out on some crucial details. They didn’t hear, for example, how its former finance chief said the system would make an extra $200 million per year by making insurers contract with all of its hospitals instead of just a few. Or how its former CEO said, “Related to the health plans, we force them to pay us more.”

That evidence was indeed relevant, and the judge erred by not allowing it to be presented during the month-long trial that concluded in March 2022, a U.S. appeals court wrote in its ruling on Tuesday. The Ninth Circuit panel overturned Sutter’s win in the class-action case alleging that Sutter used its market power to drive up health care costs across the region by more than $400 million. Tuesday’s decision means the case will likely get a second trial.

“Effectively, the appellate court said the jury was tainted,” said Matthew Cantor, lead counsel for the plaintiffs. “So the jury’s verdict is discarded.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Russian fighter jet damages US Reaper drone with flare over Syria: Officials

explore

WSS

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

Why patients can’t get everything they want on drug pricing

New lawsuit accuses health insurer Cigna of denying claims in bulk

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

Prime Medicine says its gene editing passes test in monkeys

CDC Director Mandy Cohen on transparency, trust, and health

explore

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

focus

Alkermes shareholders re

Life sciences investors close nearly $6 billion in new funds

Alkermes shareholders re

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

The high cost of giving birth even with insurance

DeepMind touts AlphaFold's new skills as protein folding AI models face off

DIEP, the 'gold standard' of breast reconstruction, is under threat

Inari Medical to buy amputation prevention company LimFlow

Cancer drug shortages should be causing more outrage

What it's like to live with paralysis for one psychologist

entertainment

Will the FTC rein in IQVIA's health data empire?

Gene therapy’s promise and the high cost of hope

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

Lung cancer screening guidelines updated for cigarette smokers

CDC Director Mandy Cohen on transparency, trust, and health

How neuroscience research could help beat back brain cancer

explore

hotspot

knowledge

Wikipedia